EGR1 Haploinsufficiency Confers a Fitness Advantage to Hematopoietic Stem Cells Following Chemotherapy.
Exp Hematol
; 115: 54-67, 2022 11.
Article
in En
| MEDLINE
| ID: mdl-35995095
Full text:
1
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cells
/
Haploinsufficiency
Type of study:
Prognostic_studies
Limits:
Aged
/
Animals
/
Humans
Language:
En
Journal:
Exp Hematol
Year:
2022
Type:
Article